Metroplasty and myomectomy with the CO2 laser for maximizing the preservation of normal tissue and minimizing blood loss.
A study was designed to evaluate the efficacy of the CO2 laser in performing conservative uterine surgery, metroplasty and myomectomy; to determine blood loss using this technique; and to ascertain how much normal uterine tissue was preserved. To assess the effectiveness of this new surgical technique, 22 patients underwent metroplasty, myomectomy or both utilizing the CO2 laser. The blood loss via microlaser surgery was compared to that in a group of 14 patients who underwent conventional surgery. The initial findings indicated that the CO2 laser is a viable surgical instrument for myomectomy and metroplasty and that its use yields less blood loss and greater preservation of normal tissue.
D000328:Adult; D002245:Carbon Dioxide; D005260:Female; D006488:Hemostasis, Surgical; D006801:Humans; D007431:Intraoperative Complications; D053685:Laser Therapy; D007889:Leiomyoma / Q000601:surgery*; D014592:Uterine Hemorrhage / Q000517:prevention & control; D014594:Uterine Neoplasms / Q000601:surgery*; D014599:Uterus / Q000002:abnormalities / Q000601:surgery*
D002245:Carbon Dioxide